Vindon Opens Pharma Storage Site in California

By Dan Stanton

- Last updated on GMT

Vindon Opens Pharma Storage Site in California

Related tags: Pharmacology

Vindon has opened the doors of a new US biopharmaceutical storage facility to service Californian and West Coast drug firms.

Vindon’s 7000 cubic feet expansion in Santa Fe Springs “has made it the largest pharmaceutical and biostorage facility in California,”​ according to Operations Manager Lindsay Haney, offering both pharma and biopharma firms a number of storage services.

Haney told Outsourcing-Pharma.com among the services the firm could now offer a host of West Coast clients was DEA Schedules I-V storage, stability storage with a full range of ICH and unique conditions and low and ultralow storage for biologics, tissues and vaccines.

Furthermore, the firm can also offer pharmaceutical testing and analytical services through a partnership located next door, as well as a full range of validation and calibration services, Haney said.

With this new facility, she said, “Vindon has guaranteed we have all the appropriate quality systems in place and can ensure the integrity of the product will be maintained.”

The site is Vindon’s second in the US and will have three fulltime employees on site.

Outsourcing Storage

The news comes just months after Vindon announced it was upping its capacity​ the other side of the pond, with its storage facility in County Waterford, Ireland, increasing to 12,360 cubic feet.

Speaking with Outsourcing-Pharma.com in March, Vindon’s Director Patrick Jackson said pharma companies were watching their outgoing costs, especially with a number of firms being hit by weak pipelines and patent expirations.

Therefore, he added, “it makes economic sense to outsource stability storage as development comes in peaks and troughs so the storage requirements are the same, therefore they only pay for the service when required.”

Related news

Related product

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us

Products

View more

Webinars